U-M research: New plastic is strong as steel, t... ( ANN ARBOR Mich.---By mimicking a bri...)

U-M research: New plastic is strong as steel, transparent

Date:10/4/2007

ANN ARBOR, Mich.---By mimicking a brick-and-mortar molecular structure found in seashells, University of Michigan researchers created a composite plastic that's as strong as steel but lighter and transparent.

It's made of layers of clay nanosheets and a water-soluble polymer that shares chemistry with white glue.

Engineering professor Nicholas Kotov almost dubbed it "plastic steel," but the new material isn't quite stretchy enough to earn that name. Nevertheless, he says its further development could lead to lighter, stronger armor for soldiers or police and their vehicles. It could also be used in microelectromechanical devices, microfluidics, biomedical sensors and valves and unmanned aircraft.

Kotov and other U-M faculty members are authors of a paper on this composite material, "Ultrastrong and Stiff Layered Polymer Nanocomposites," published in the Oct. 5 edition of Science.

The scientists solved a problem that has confounded engineers and scientists for decades: Individual nano-size building blocks such as nanotubes, nanosheets and nanorods are ultrastrong. But larger materials made out of bonded nano-size building blocks were comparatively weak. Until now.

"When you tried to build something you can hold in your arms, scientists had difficulties transferring the strength of individual nanosheets or nanotubes to the entire material," Kotov said. "We've demonstrated that one can achieve almost ideal transfer of stress between nanosheets and a polymer matrix."

The researchers created this new composite plastic with a machine they developed that builds materials one nanoscale layer after another.

The robotic machine consists of an arm that hovers over a wheel of vials of different liquids. In this case, the arm held a piece of glass about the size of a stick of gum on which it built the new material.

The arm dipped the glass into the glue-like polymer solution and then into a liqu
'/>"/>

Contact: Nicole Casal Moore
ncmoore@umich.edu
734-647-1838
University of Michigan
Source:Eurekalert

1

GOOD

Page: 1 2
Related biology technology :

1. Proteomics in Bladder Cancer Research: Protein Profiling of Bladder Squamous Cell Carcinomas, Rev C
2. A week in UW research: fusion, racing and sleep
3. Phillips Plastics to help develop orthopedics with stem cells
4. Wisconsin identity theft law: A cheap plastic sword
5. UWM receives state funding for plastics research
6. Lance Armstrong and the future of cancer care
7. Entrepreneurship grant will build strong foundation
8. Corporate control begins with a strong board
9. Midwest colleges strong contenders for NIH funds
10. Fiserv reports stronger earnings and revenues
11. Third Wave reports another loss, stronger sales

Post Your Comments:

(Date:2/9/2010)... Belgium , February 9 /PRNewswire-FirstCall/ ... Examines the Potential of Microplasmin to Improve the ... Diseases ,, ThromboGenics NV ... discovery and development of innovative treatments for eye,disease, ... positive,microplasmin Phase II trial results, evaluating the product,s ...

(Date:2/8/2010)... MISSISSAUGA, ON , Feb. 8 /PRNewswire-FirstCall/ ... YM), today reported operational and financial results for ... December 31, 2009 . ,, "After rigorous evaluation ... merge Cytopia Limited., a clinical-stage, Melbourne -based ... quarter," said David Allan , Chairman & ...

(Date:2/8/2010)... CMED ), a leading China -based advanced in-vitro,diagnostic ("IVD") company, today announced that it will ... Conference Date ... Renshaw Annual March 7-9, 2010 The Regent ... ... Credit Suisse Asian March 22-26, ...

(Date:2/8/2010)... five months ahead of schedule ,, TSX Exchange Symbol: ... Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today ... clinical study of its lead drug RVX-208. "The completion ... full 5 months ahead of our original schedule, is ... collaborators at the Cleveland Clinic. At this rate we ...

[0] ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology [0] YM BioSciences reports second quarter 2010 operational and financial results [0] China Medical Technologies to Participate Investor Conferences in March 2010 [0] Resverlogix Completes Patient Recruitment for ASSERT Trial

... July 17 Following intense,speculation in sections ... Daiichi Sankyo,Company, Limited (TSE: 4568.JP) ("Daiichi Sankyo") ... that the agreement,between Daiichi Sankyo, Ranbaxy and ... Ranbaxy, is binding and final, subject to,regulatory ...

... Supply Solutions(R),a focus area within SAFC(R), a ... today that the Company has launched a ... with their regulatory,requirement under the new European ... Authorization and restriction of Chemicals,(REACH) http://www.safcsupplysolutions.com/reach ...

... have combined the efforts of two kinds of bacteria to ... providing food for the other. According to an article in ... has an added bonus: leftover enzymes can be used to ... fuel cells that convert hydrogen into energy. , Hydrogen has ...

Other Biology Technology:Daiichi Sankyo and Ranbaxy Confirm Deal Is Binding and Final, Allay Market Rumour and Speculation 2 SAFC Supply Solutions Launches REACH-Compliant Products and Support 2 SAFC Supply Solutions Launches REACH-Compliant Products and Support 3 Fuel from food waste: bacteria provide power 2

Daiichi Sankyo and Ranbaxy Confirm Deal Is Binding and Final, Allay Market Rumour and Speculation SAFC Supply Solutions Launches REACH-Compliant Products and Support Fuel from food waste: bacteria provide power

(Date:2/8/2010)... February 9, 2010 Cellular imaging offers a wealth ... harnessing this technique to study biological systems is a ... Genome Research ( www.genome.org ), researchers have ... images to identify genetic interactions within biological networks, offering ... analysis. , For years, scientists have been peering through ...

(Date:2/8/2010)... The nation,s first fully integrated collaboration ... improve health and reduce healthcare spending has been ... . The Full Yield rolls out in greater ... exclusive partnership with Harvard Pilgrim Health Care ... the U.S., and an inaugural partnership with ...

(Date:2/7/2010)... habits or behaviors, like cigarette smoking, may influence the ... HPV. , According to survey results on correlates ... vaccinate their daughters was not associated with one,s background ... certain behavioral factors of the parents. , Results of ... Cancer Epidemiology, Biomarkers & Prevention , a journal ...

[0] Method of the future uses single-cell imaging to identify gene interactions [0] The Full Yield, Inc. Launches Breakthrough Collaboration to Put Food Back at the Heart of Healthcare [0] More smokers than non-smokers accept HPV vaccination for their daughters

... is a life-threatening disease caused by exposure to botulinum ... These neurotoxins are produced by Clostridium botulinum, a bacterium ... toxins bind to and enter neurons, interfering with nerve ... muscle fibers throughout the body. Poisoning with botulinum toxins ...

... outcome from traditional radiation and chemotherapy treatment for head ... a good prognosis with treatment of p53 tumor suppressor ... biomarker test for a gene-based drug. , Researchers at ... with advanced squamous cell carcinoma of the head and ...

... Library of Science (PLoS) announced today the creation ... access journal devoted to the world's most neglected ... ) will focus on the overlooked diseases that ... countries, including elephantiasis, river blindness, leprosy, hookworm, schistosomiasis, ...

Other Biology News:Abnormal overexpression of p53 is a predictive molecular biomarker 2 Public Library of Science to launch new, open access journal on neglected tropical diseases 2 Public Library of Science to launch new, open access journal on neglected tropical diseases 3

Molecular structure reveals how botulinum toxin attaches to nerve cells Abnormal overexpression of p53 is a predictive molecular biomarker Public Library of Science to launch new, open access journal on neglected tropical diseases

Assay Diluent Trial Pack, 4 x 100 mL...

... Immunogen: Synthetic peptide derived from ... junctophilin-3. Specificity: Specific for the ... Reactivity: Mouse (positive controls: mouse ... heart tissues). Applications: Western blotting ...

Rabbit anti-Junctophilin-4 (C-term)...

SpectroQuest single beam 4nm UV/Vis spectrophotometer; stand-alone unit; large angled LCD screen; large sample compartment...

Biology Products:

Assay Diluent Trial Pack from BioFX Laboratories, Inc.Rabbit Anti-Mouse Junctophilin-3 (Mid) Monoclonal Antibody, Clone ZMD.474 from Invitrogen Rabbit Anti-Mouse Junctophilin-4, C-Terminus Monoclonal Antibody, Unconjugated, Clone PADZMD.487 from Invitrogen UNICO Spectrophotometer from Femto Scientific

U-M research: New plastic is strong as steel, t...( ANN ARBOR Mich.---By mimicking a bri...)